Table 1.
Characteristic | Total (n = 77) | Control (n = 38) | MAFLD (n = 39) | p-Value |
---|---|---|---|---|
Age (years), median (IQR) | 46 (30–56) | 30 (27–41.5) | 53 (48.5–58.5) | <0.001 |
Gender (male), n (%) | 35 (45.45) | 17 (44.74) | 18 (46.15) | 0.901 |
Marital Status: | <0.001 | |||
Single, n (%) | 21 (27.27) | 18 (47.37) | 3 (7.69) | |
Married, n (%) | 51 (66.23) | 19 (50) | 32 (82.05) | |
Divorced, n (%) | 3 (3.9) | 0 (0) | 3 (7.69) | |
Widow, n (%) | 2 (2.6) | 1 (2.63) | 1 (2.56) | |
Married (yes), n (%) | 51 (66.23) | 19 (50) | 32 (82.05) | 0.003 |
Education: | ||||
Primary School, n (%) | 3 (3.9) | 0 (0) | 3 (7.69) | <0.001 |
Middle School, n (%) | 12 (15.58) | 4 (10.53) | 8 (20.51) | |
High School, n (%) | 27 (35.06) | 7 (18.42) | 20 (51.28) | |
Undergraduate Course, n (%) | 6 (7.79) | 5 (13.16) | 1 (2.56) | |
University, n (%) | 26 (33.77) | 21 (55.26) | 5 (12.82) | |
Post-graduate, n (%) | 3/77 (3.9) | 1 (2.63) | 2 (5.13) | |
Menopausal status: * | <0.001 | |||
Premenopause | 21 (50) | 18 (42.86) | 3 (7.14) | |
Menopause | 21 (50) | 3 (7.14) | 18 (42.86) | |
Metabolic syndrome (yes), n (%) | 32 (41.56) | 2 (5.26) | 30 (76.92) | <0.001 |
BMI, median (IQR) | 26.57 (22.22–31.44) | 22.18 (20.15–24.95) | 31.18 (28.08–34.98) | <0.001 |
Obesity (yes), n (%) | 22 (28.57) | 1 (2.63) | 21 (53.85) | <0.001 |
Hepatic steatosis (US) (yes), n (%) | 39 (50.65) | 0 (0) | 39 (100) | <0.001 |
SteatoTest score, median (IQR) | 0.39 (0.13–0.62) | 0.13 (0.08–0.21) | 0.62 (0.51–0.72) | <0.001 |
SBP-mean (mmHg), median (IQR) | 124.5 (116–137) | 120.75 (112.5–125.88) | 133 (122.25–148.25) | <0.001 |
DBP-mean (mmHg), median (IQR) | 79 (74–84) | 75 (70.75–79) | 83.5 (78.25–89) | <0.001 |
Number or medications, median (IQR) | 1 (0–4) | 0 (0–0) | 3 (1.5–5.5) | <0.001 |
* Reported in 42 female subjects. BMI—Body mass index; DBP—Diastolic blood pressure; IQR—Interquartile range; MAFLD—Metabolic-associated fatty liver disease; SBP—Systolic blood pressure.